Small-Cap Healthcare Stocks That Insiders Are Buying

Over the past couple of days, the healthcare sector has witnessed plenty of insider activity, which should not be overlooked. In this article, I will examine two small-cap companies amongst the aforementioned ones, the insider purchases, and their institutional sponsorship.

First off is AngioDynamics, Inc. (NASDAQ:ANGO), a $491 million market cap provider of medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease, and local oncology therapy options for treating cancer. On April 14th, Matthew Kapusta, Senior Vice President at the Business Development segment of the company, acquired 1,000 shares of Common Stock, despite its valuation at 126 times the company´s earnings. He paid $13.90 per share and now holds 27,005* shares of the company, worth about half a million dollars.

angiodynamics

On top of Mr. Kapusta’s bullishness, at least 19 major hedge funds hold long positions in the stock. The largest institutional sponsor, Robert G. Moses‘ Rgm Capital, recently upped his stakes slightly, to 3.44 million shares, worth more than $47 million. Israel Englander also seems to feel confident about the company’s future, as he last increased his stakes by 936% to 188,135 shares; and similar is Jim Simons’ case, who doubled his bets to 186,046 shares.

The second healthcare company I would like to refer to is Adamas Pharmaceuticals Inc (NASDAQ:ADMS), a $220 million market cap specialty pharmaceutical company focused on treating chronic disorders of the central nervous system that went public on April 10th, 2014. Credit Suisse and Piper Jaffray acted as joint book-running managers, and William Blair and Needham & Company served as co-managers.

Although Adamas is much smaller than AngioDynamics in terms of market cap, it certainly looks like a more attractive option. Trading at only 4.2 times the company´s earnings and boasting industry leading margins and returns, this is certainly a stock to consider, and insiders seem to recognize this. On the day that the IPO was closing -April 15th- William Ericson, Board Director and owner of more than 10% of the company’s stock, bought 300,000 shares for $16 per share. Mr. Ericson owns, through diverse indirect holdings, more than 4 million shares of the firm.

* “Includes 911 shares acquired under the AngioDynamics, Inc. Employee Stock Purchase Plan on February 28, 2013, 971 shares acquired under the AngioDynamics, Inc. Employee Stock Purchase Plan on August 30, 2013 and 965 shares acquired under the AngioDynamics, Inc. Employee Stock Purchase Plan on February 28, 2014 (Sec.gov).”

Disclosure: Javier Hasse holds no position in any stocks mentioned

Disclosure: none

Recommended Reading:

Two Restaurant Chain Operators That Insiders are Fond of

Insider Activity at Three of George Soros’ Picks

Insider Activity At Brown Shoe Company (BWS) and Flexsteel Industries (FLXS)

 

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The Top 10 Most Expensive Digital Cameras to Snap Stunning Shots With

The 10 Highest Quality Fast Food Restaurants In America Today

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

Top 6 Cities For The Ultra Rich to Live in Comfort

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!